Protagonist Therapeutics (PTGX) EBIT Margin (2017 - 2026)
Protagonist Therapeutics (PTGX) posted EBIT Margin of 74.37% for Q2 2026, up 832.41 percentage points from -758.04% a year earlier and up 80.84 percentage points from the prior quarter.
Powered by 
Analysis
Protagonist Therapeutics (PTGX) EBIT Margin (2017 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBIT Margin at Protagonist Therapeutics was 20.69%, up 9.23 percentage points year-over-year; for FY2025, it was -343.63%, down 401.84 percentage points from FY2024.
- Annual EBIT Margin shows a five-year change of -118.28 percentage points (FY2020 to FY2025).
- In prior years, Protagonist Therapeutics' EBIT Margin was 58.20% in FY2024 (+214.29 pp), -156.09% in FY2023 (+338.15 pp), -494.24% in FY2022 (-34.23 pp) and -460.01% in FY2021 (-234.65 pp).
- The Q2 2026 figure stands as the highest quarterly EBIT Margin since Q1 2024.
- On a year-over-year basis, EBIT Margin increased in four of the last seven quarters, with an average year-over-year change of +14.85 percentage points.
- The strongest year-over-year quarter for EBIT Margin in the past five years was Q2 2026, with a gain of 832.41 percentage points; the weakest was Q2 2022, with a drop of 3241.33 percentage points.
- According to Business Quant data, EBIT Margin for the three prior quarters was -6.47% (Q1 2026), -677.09% (Q4 2025) and -985.17% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 37.40% |
| 10 | Protagonist Therapeutics | 9.21 Bn | 9.21 Bn | - | 74.37% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 74.37% |
| Mar 31, 2026 | -6.47% |
| Dec 31, 2025 | -677.09% |
| Sep 30, 2025 | -985.17% |
| Jun 30, 2025 | -758.04% |
| Mar 31, 2025 | -68.18% |
| Dec 31, 2024 | 74.30% |
| Sep 30, 2024 | -886.70% |
| Jun 30, 2024 | -930.96% |
| Mar 31, 2024 | 80.92% |
| Dec 31, 2023 | 38.42% |
| Jun 30, 2022 | -4,604.78% |
| Mar 31, 2022 | -82.07% |
| Dec 31, 2021 | -429.57% |
| Sep 30, 2021 | -329.83% |
| Jun 30, 2021 | -1,363.44% |
| Mar 31, 2021 | -388.12% |
| Dec 31, 2020 | -333.27% |
| Sep 30, 2020 | -59.26% |
| Jun 30, 2020 | -293.02% |
API Access
Protagonist Therapeutics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=PTGX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "PTGX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=PTGX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();